方正電機(002196.SZ):持股5%以上股東張敏短線交易收警示函
格隆匯3月1日丨方正電機(002196.SZ)公佈,公司於2022年3月1日收到股東張敏出具的吿知函,獲悉張敏於2022年2月28日收到浙江證監局出具的《關於對張敏採取出具警示函措施的決定》(【2022】21號)。
張敏作為公司持股5%以上股東,於2022年1月14日賣出公司股票498.27萬股,成交金額約6205.37萬元,並於當日買入公司股票35.24萬股,成交金額約442.26萬元。
上述六個月內買賣公司股票的行為構成短線交易,違反了《中華人民共和國證券法》第四十四條的規定。浙江證監局決定對張敏採取出具警示函的監督管理措施,並記入證券期貨市場誠信檔案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.